Paasa Logo
iShares Nasdaq US Biotechnology UCITS ETF logo
BTEELSEMarket openCloses 4:30pm UK

iShares Nasdaq US Biotechnology UCITS ETF

$10.50Last updated
-$0.13 (1.18%)Past day
Timezone

iShares Nasdaq US Biotechnology UCITS ETF (LSE: BTEE) is an exchange-traded fund listed on the London Stock Exchange ETF segment, trading at $10.50 (about ₹988 a unit) as of 13 Nov 2026, 5:27 AM ET. It has an expense ratio of 0.35% and holds 250 securities. Indian residents can buy BTEE through Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$10.51
Previous close:$10.63
Volume:574.00

Today's low

$10.47

Today's high

$10.53

52 week low

$7.89

52 week high

$10.88

BTEE opened at $10.51, closed previously at $10.63, and has traded between $7.89 and $10.88 over the past 52 weeks.

About

The iShares Nasdaq US Biotechnology UCITS ETF is structured to mirror the financial performance of a specific underlying index. This index comprises equities of biotechnology and pharmaceutical companies based in the US, which are primarily traded on the NASDAQ exchange.

Issuer
IShares
Exchange listed on
LSE
Asset class
Equity
Base currency
USD
Domicile
Ireland
Dividends
Distributing
Launched
2018
ISIN
IE00BDZVHG35

Key statistics

Expense ratio

0.35%

Assets (AUM)

$78.8M

Holdings

250

NAV

$10.49

Avg. volume

36.74K

1-year price change

+30.92%

5-year price change

+49.57%

Price change excludes dividends.

Top 10 holdings

1. GILEAD SCIENCES
8.9%
2. AMGEN INC
8.3%
3. VERTEX PHARMACEUTICALS
7.7%
4. MODERNA
6.2%
5. REGENERON PHARMACEUTICALS
6.1%
6. REVOLUTION MEDICINES
2.4%
7. BIOGEN
2.4%
8. ILLUMINA INC
2.0%
9. ROYALTY PHARMA PLC CLASS A
2.0%
10. ROIVANT SCIENCES LTD
1.9%

BTEE holds 250 securities in total. These 10 are 47.9% of the fund.

Where the money is invested

Countries

United States
95.2%
United Kingdom
1.9%
France
1.0%
Canada
0.5%
Netherlands
0.4%
Denmark
0.3%

Similar funds

This is not an investment recommendation

How to buy BTEE from India

Indian residents can buy BTEE units through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the units are held in your own name with Interactive Brokers. Read the full guide: how to invest in BTEE from India

  1. Open your Paasa account

    KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds from your Indian bank account

    Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.

  3. Search BTEE and buy

    Find the fund by its ticker, BTEE, on the London Stock Exchange ETF segment, and place your order.

  4. Track holdings and download tax reports

    Follow your BTEE position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Trading and taxes when buying BTEE from India

Trading and limits

Trading hours
8:00 am – 4:30 pm UK
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation. Gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateIt pays the dividends from its holdings out to you in cash, and dividends are taxed at your slab rate in India.Dividend tax explained

FAQs

What is the BTEE price today?

iShares Nasdaq US Biotechnology UCITS ETF (BTEE) last traded at $10.50 on the London Stock Exchange ETF segment, as of 13 Nov 2026, 5:27 AM ET. That is ₹988 a unit at the 12 Nov 2026 USD/INR rate.

When does BTEE trade, in Indian time?

The London Stock Exchange ETF segment trades 1:30 pm – 10:00 pm IST. The window shifts to 12:30 pm – 9:00 pm IST when the UK is on daylight time. Orders can only execute during that window.

How big is BTEE, and what does it cost to hold?

iShares Nasdaq US Biotechnology UCITS ETF manages about $78.8M. Its expense ratio is 0.35% a year, deducted inside the fund. It launched in 2018.

Is BTEE a UCITS ETF?

Yes. iShares Nasdaq US Biotechnology UCITS ETF is a UCITS fund domiciled in Ireland, set up under the European Union's UCITS rules for funds sold across Europe. It is listed on the London Stock Exchange ETF segment and trades in US dollars.

What are BTEE's largest holdings?

The top three are GILEAD SCIENCES (8.9%), AMGEN INC (8.3%) and VERTEX PHARMACEUTICALS (7.7%). BTEE's 10 largest positions make up 47.9% of the fund.

Is BTEE subject to US estate tax?

No. Because BTEE is domiciled in Ireland rather than the US, it is not a US-situs asset, so US estate tax does not apply to it. US-listed ETFs held directly can be taxed at up to 40% above $60,000 when they pass to your family.

Is BTEE accumulating or distributing?

Distributing. It pays dividends out to you in cash, taxed at your slab rate in India.

How are US dividends taxed inside BTEE?

The US withholds 15% on dividends from the US shares the fund holds, and that tax is paid inside the fund. You cannot claim it as a Foreign Tax Credit in India.

How are gains on BTEE taxed in India?

Units held for more than 24 months are long-term and taxed at 12.5% without indexation; units held for 24 months or less are taxed at your income-tax slab rate. The gain is worked out in rupees, so the currency move counts.

How has BTEE performed?

BTEE's price is up 30.9% over the past year and up 49.6% over five years. These figures are price change only and exclude dividends; past performance does not guarantee future returns.

How is BTEE different from a US-listed ETF?

BTEE is domiciled in Ireland rather than the US. That keeps it outside US estate tax, and dividend withholding on its US shares is 15%, paid inside the fund, instead of the 25% withheld on a US-listed ETF. The 25% can generally be claimed as a credit in India; the 15% cannot. Capital gains on both are taxed the same way in India.